St. Jude's $167 Mil. Angio-Seal Puncture Closure Buy Adds $50 Mil. In Sales
This article was originally published in The Gray Sheet
Executive Summary
St. Jude's $167 mil. cash acquisition of marketing and manufacturing rights to Kensey Nash's Angio-Seal hemostatic puncture closure device from Tyco International would "more than double" sales into the cardiology cath lab by St. Jude's Daig division and add 60 to its sales and marketing staff, the firm states.